Acorda Says Tribunal Ignored Patent Law In MS Drug Feud
IP Law 360
MARCH 19, 2024
million it won in arbitration against Irish biopharmaceutical company Alkermes in a licensing fight over a multiple sclerosis drug, arguing that the tribunal disregarded clear patent law. Acorda Pharmaceuticals pressed the Federal Circuit to award it nearly $66 million more than the $16.5
Let's personalize your content